Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer
- 31 August 1996
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 18 (4), 647-657
- https://doi.org/10.1016/s0149-2918(96)80215-3
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- LeuprorelinDrugs, 1994
- Clinical Study of Leuprolide Depot Formulation in the Treatment of Advanced Prostate CancerJournal of Urology, 1990
- Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)Cancer, 1980